Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study

References

1. 1.↵
   1. Alizadeh AA,
   2. Eisen MB,
   3. Davis RE,
   4. et al

   . Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–11

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Perou CM,
   2. Sørlie T,
   3. Eisen MB,
   4. et al

   . Molecular portraits of human breast tumours. Nature 2000;406:747–52

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Phillips HS,
   2. Kharbanda S,
   3. Chen R,
   4. et al

   . Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression and resemble stages in neurogenesis. Cancer Cell 2006;9:157–73

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Verhaak RG,
   2. Hoadley KA,
   3. Purdom E,
   4. et al

   . Cancer Genome Atlas Research Network integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98–110

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Cooper LA,
   2. Kong J,
   3. Gutman DA,
   4. et al

   . An integrative approach for in silico glioma research. IEEE Trans Biomed Eng 2010;57:2617–21. Epub 2010 Jul 23

   CrossRefPubMed
6. 6.↵
   1. Van Meter T,
   2. Dumur C,
   3. Hafez N,
   4. et al

   . Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets. Diagn Mol Pathol 2006;15:195–205

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Pope WB,
   2. Chen JH,
   3. Dong J,
   4. et al

   . Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology 2008;249:268–77

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Diehn M,
   2. Nardini C,
   3. Wang DS,
   4. et al

   . Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A 2008;105:5213–18

   Abstract/FREE Full Text
9. 9.↵
   1. Barajas RF Jr.,
   2. Hodgson JG,
   3. Chang JS,
   4. et al

   . Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology 2010;254:564–76

   CrossRefPubMedWeb of Science
10. 10.↵
    Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061–68. Epub 2008 Sep 4

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Jain R,
    2. Ellika SK,
    3. Scarpace L,
    4. et al

    . Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol 2008;29:694–700

    Abstract/FREE Full Text
12. 12.↵
    1. The Cancer Genome Atlas.

    TCGA Data Portal Overview. Preprocessed level 2 data. http://tcga-data.nci.nih.gov/tcga. Accessed July 1, 2011.
13. 13.↵
    1. Smyth GK,
    2. Speed TP

    . Normalization of cDNA microarray data. Methods 2003;31:265–73

    CrossRefPubMedWeb of Science
14. 14.↵
    The Gene Ontology. http://geneontology.org/. Accessed December 15, 2010.
15. 15.↵
    1. Eisen MB,
    2. Spellman PT,
    3. Brown PO,
    4. et al

    . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95: 14863
16. 16.↵
    1. Sato Y,
    2. Sonoda H

    . The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler Thromb Vasc Biol 2007;27:37–41

    Abstract/FREE Full Text
17. 17.↵
    1. Kimura H,
    2. Miyashita H,
    3. Suzuki Y,
    4. et al

    . Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood 2009;113:4810–18

    Abstract/FREE Full Text
18. 18.↵
    1. Masckauchan TN,
    2. Agalliu D,
    3. Vorontchikhina M,
    4. et al

    . Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and TIE2. Mol Biol Cell 2006;17:5163–72. Epub 2006 Oct 11

    Abstract/FREE Full Text
19. 19.↵
    1. Goodwin AM,
    2. Kitajewski J,
    3. D'Amore PA

    . Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not. Growth Factors 2007;25:25–32

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Kamino M,
    2. Kishida M,
    3. Kibe T,
    4. et al

    . Wnt5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci 2011;102:540–48

    CrossRefPubMed
21. 21.↵
    1. Erreni M,
    2. Solinas G,
    3. Brescia P,
    4. et al

    . Human glioblastoma tumours and neural cancer stem cells express the chemokine CX3CL1 and its receptor CX3CR1. Eur J Cancer 2010;46:3383–92

    CrossRefPubMed
22. 22.↵
    1. Sui XF,
    2. Kiser TD,
    3. Hyun SW,
    4. et al

    . Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia. Am J Pathol 2005;166:1247–58

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Li Z,
    2. Bao S,
    3. Wu Q,
    4. et al

    . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009;15:501–03

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Gerhardt H

    . VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008;4:241–46

    CrossRefPubMed
25. 25.↵
    1. Berx G,
    2. van Roy F

    . Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 2009;1:a003129

    Abstract/FREE Full Text
26. 26.↵
    1. Jasielska M,
    2. Semkova I,
    3. Shi X,
    4. et al

    . Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 2010;51:3874–83

    Abstract/FREE Full Text
27. 27.↵
    1. Singh H,
    2. Milner CS,
    3. Aquilar Hernandez MM,
    4. et al

    . VEGF activates the TIE family of receptor tyrosine kinases. Cell Signal 2009;21:1346–50

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Xu Z,
    2. Yu Y,
    3. Duh EJ

    . Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling. Invest Ophthal Vis Sci 2006;47:4059–66

    Abstract/FREE Full Text
29. 29.↵
    1. Kouno J,
    2. Nagai H,
    3. Nagahata,
    4. et al

    . Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma promotes cell growth. J Neurooncol 2004;70:301–07

    CrossRefPubMed
30. 30.↵
    1. Bratt A,
    2. Birot O,
    3. Sinha I,
    4. et al

    . Angiomotin regulates endothelial cell-cell junctions and cell motility. J Biol Chem 2005;280:34859–69

    Abstract/FREE Full Text
31. 31.↵
    1. Primo L,
    2. Ferrandi C,
    3. Roca C,
    4. et al

    . Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J 2005;19:1713–15

    Abstract/FREE Full Text
32. 32.↵
    1. Bernardi R,
    2. Guernah I,
    3. Jin D,
    4. et al

    . PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 2006;17: 442: 779–85
33. 33.↵
    1. Kamei CN,
    2. Kempf H,
    3. Yelin R,
    4. et al

    . Promotion of avian endothelial cell differentiation by GATA transcription factors. Dev Biol 2011;353:29–37

    CrossRefPubMed
34. 34.↵
    1. Mattsson JM,
    2. Laakkonen P,
    3. Stenman UH,
    4. et al

    . Antiangiogenic properties of prostate-specific antigen (PSA). Scand J Clin Lab Invest 2009;69:447–51

    CrossRefPubMed
35. 35.↵
    1. Langer HF,
    2. Chung KJ,
    3. Orlova W,
    4. et al

    . Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010;116:4395–403

    Abstract/FREE Full Text
36. 36.↵
    1. Vonov E,
    2. Shouval DS,
    3. Krelin Y,
    4. et al

    . IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 2003;100:2645–50

    Abstract/FREE Full Text
37. 37.↵
    1. Stratmann A,
    2. Risau W,
    3. Plate KH

    . Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 1998;153:1459–66

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Augustin HG,
    2. Koh GY,
    3. Thurston G,
    4. et al

    . Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009;10:165–77

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Bornstein P,
    2. Kyriakides TR,
    3. Yang Z,
    4. et al

    . Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis. J Invest Dermatol Symp Proc 2000;5:61–66

    CrossRef
40. 40.↵
    1. Aronen HJ,
    2. Gazit IE,
    3. Louis DN,
    4. et al

    . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Law M,
    2. Yang S,
    3. Babb JS,
    4. et al

    . Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

    Abstract/FREE Full Text
42. 42.↵
    1. Law M,
    2. Oh S,
    3. Babb JS,
    4. et al

    . Low-grade gliomas: Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 2006;238:658

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Mills SJ,
    2. Patankar TA,
    3. Haroon HA,
    4. et al

    . Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853–58

    Abstract/FREE Full Text
44. 44.↵
    1. Ellika SK,
    2. Jain R,
    3. Patel SC,
    4. et al

    . Role of perfusion CT in glioma grading and comparison with conventional MR imaging features. AJNR Am J Neuroradiol 2007;28:1981–87

    Abstract/FREE Full Text
45. 45.↵
    1. Jain R,
    2. Gutierrez J,
    3. Narang J,
    4. et al

    . In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in glioma. AJNR Am J Neuroradiol 2011;32:388–94

    Abstract/FREE Full Text
46. 46.↵
    1. Iruela-Arispe ML,
    2. Davis GE

    . Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 2009;16:222–31

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Dejana E,
    2. Tournier-Lasserve E,
    3. Weinstein BM

    . The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009;16:209–21

    CrossRefPubMedWeb of Science
48. 48.↵
    1. von Tell D,
    2. Armulik A,
    3. Betsholtz C

    . Pericytes and vascular stability. Exp Cell Res 2006;312:623–29

    CrossRefPubMedWeb of Science
49. 49.↵
    1. Bridges EM,
    2. Harris AL

    . The angiogenic process as a therapeutic target in cancer. Biochem Pharmacol 2011;81:1183–91. Epub 2011 Mar 4

    CrossRefPubMed
50. 50.↵
    1. Paulino VM,
    2. Yang Z,
    3. Kloss J,
    4. et al

    . TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res 2010;8:1558–67

    Abstract/FREE Full Text
51. 51.↵
    1. Pietras K,
    2. Ostman A

    . Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010;316:1324–31

    CrossRefPubMedWeb of Science
52. 52.↵
    1. Cornelius LA,
    2. Nehring LC,
    3. Harding E,
    4. et al

    . Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 1998;161:6845–52

    Abstract/FREE Full Text
53. 53.↵
    1. Kalebic T,
    2. Garbisa S,
    3. Glaser B,
    4. et al

    . Basement membrane collagen: degradation by migrating endothelial cells. Science 1983;221:281–83

    Abstract/FREE Full Text
54. 54.↵
    1. Sercu S,
    2. Zhang L,
    3. Merregaert J

    . The extracellular matrix protein 1: its molecular interaction and implication in tumor progression. Cancer Invest 2008;26:375–84

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Beenken A,
    2. Mohammadi M

    . The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Disc 2009;8:235–53

    CrossRefPubMedWeb of Science